Importance of Candida Antigenic Factors: Structure-Driven Immunomodulation Properties of Synthetically Prepared Mannooligosaccharides in RAW264.7 Macrophages
Open Access
- 8 November 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 9, 378
Abstract
The incidence and prevalence of serious fungal infections is rising, especially in immunosuppressed individuals. Moreover, co-administration of antibiotics and immunosuppressants has driven the emergence of new multidrug-resistant pathogens. The significant increase of multidrug-resistant pathogens, together with their ability to form biofilms, is associated with morbidity and mortality. Research on novel synthetically prepared immunomodulators as potential antifungal immunotherapeutics is of serious interest. Our study demonstrated the immunobiological activity of synthetically prepared biotinylated mannooligosaccharides mimicking Candida antigenic factors using RAW264.7 macrophages. Macrophage exposure to the set of eight structurally different mannooligosaccharides induced a release of Th1, Th2, Th17, and Treg cytokine signature patterns. The observed immune responses were tightly associated with structure, dose, exposure time, and selected signature cytokines. The viability/cytotoxicity of the mannooligosaccharide formulas was assessed based on cell proliferation. The structure-based immunomodulatory activity of the formulas was evaluated with respect to the length, branching and conformation of the various formulas. Glycoconjugate formulas with terminal β-mannosyl-units tended to be more potent in terms of Candida relevant cytokines IL-12 p70, IL-17, GM-CSF, IL-6, and TNFα induction and cell proliferation, and this tendency was associated with structural differences between the studied glycoconjugate formulas. The eight tested mannooligosaccharide conjugates can be considered potential in vitro immunomodulative agents suitable for in vitro Candida diagnostics or prospectively for subcellular anti-Candida vaccine design.Keywords
Funding Information
- Russian Science Foundation (19-73-30017)
- Agentúra na Podporu Výskumu a Vývoja
This publication has 110 references indexed in Scilit:
- Differential Virulence of Candida glabrata Glycosylation MutantsJournal of Biological Chemistry, 2013
- Mannan structural complexity is decreased when Candida albicans is cultivated in blood or serum at physiological temperatureCarbohydrate Research, 2011
- Fungal recognition is mediated by the association of dectin-1 and galectin-3 in macrophagesProceedings of the National Academy of Sciences, 2011
- T-cell Subsets and Antifungal Host DefensesCurrent Fungal Infection Reports, 2010
- Contribution ofCandida albicansCell Wall Components to Recognition by and Escape from Murine MacrophagesInfection and Immunity, 2010
- Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasisProceedings of the National Academy of Sciences, 2008
- Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicansAntimicrobial Agents and Chemotherapy, 2008
- Syk kinase is required for collaborative cytokine production induced through Dectin‐1 and Toll‐like receptorsEuropean Journal of Immunology, 2008
- Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal formsBiochemical Journal, 2007
- Dectin-1 is required for β-glucan recognition and control of fungal infectionNature Immunology, 2006